Premature conclusions may harm good ideas.
Staudenherz
Anton
A
Sinzinger
Helmut
H
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000097:blood / Q000000981:diagnostic imaging* / Q000401:mortality* / Q000556:secondary; D002574:Cervical Vertebrae / Q000000981:diagnostic imaging; D018572:Disease-Free Survival; D019008:Drug Resistance, Neoplasm; D006801:Humans; D015994:Incidence; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging; D008297:Male; D009426:Netherlands / Q000453:epidemiology; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000401:mortality*; D011877:Radionuclide Imaging; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D013117:Spinal Cord Compression / Q000097:blood / Q000000981:diagnostic imaging* / Q000209:etiology; D013904:Thoracic Vertebrae / Q000000981:diagnostic imaging
D018931:Antineoplastic Agents, Hormonal; D017430:Prostate-Specific Antigen
Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):958-63
14985870
Urol Int. 1985;40(1):45-7
3156441
Semin Nucl Med. 2001 Jan;31(1):3-16
11200204
Acta Radiol. 2000 Mar;41(2):183-8
10741795
Oncology. 2003;65 Suppl 1:5-11
12949427
Cancer. 1990 Sep 1;66(5 Suppl):1017-21
2393845
J Urol. 2000 Oct;164(4):1248-53
10992374
Clin Nucl Med. 1999 Jun;24(6):407-13
10361935
Nuklearmedizin. 1997 Mar;36(2):52-5
9090647
Anticancer Res. 2000 Mar-Apr;20(2B):1115-20
10810405